Chronic metabolic acidosis in azotemic rats on a high-phosphate diet halts the progression of renal disease

被引:45
|
作者
Jara, A
Felsenfeld, AJ
Bover, J
Kleeman, CR
机构
[1] W Los Angeles Vet Affairs Med Ctr, Dept Med, Los Angeles, CA 90073 USA
[2] Univ Calif Los Angeles, Los Angeles, CA USA
关键词
bone; calcium; parathyroid hormone; hyperphosphatemia; chronic renal failure; diet; mineral metabolism;
D O I
10.1046/j.1523-1755.2000.00260.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background. Hyperphosphatemia and metabolic acidosis are general features of advanced chronic renal failure (RF), and each may affect mineral metabolism. The goal of the present study was to evaluate the effect of chronic metabolic acidosis on the development of hyperparathyroidism and bone disease in normal and azotemic rats on a high-phosphate diet. Our assumption that the two groups of azotemic rats (acid-loaded vs. non-acid-loaded) would have the same degree of renal failure at the end of the study proved to be incorrect. Methods. Four groups of rats receiving a high-phosphate (1.2%), normal-calcium (0.6%) diet for 30 days were studied: (I) normal (N); (2) normal + acid (N + Ac) in which 1.5% ammonium chloride (NH4Cl) was added to the drinking water to induce acidosis; (3) RF, 5/6 nephrectomized rats; and (4) RF + acid (RF + Ac) in which 0.75% NH4Cl was added to the drinking water of 5/6 nephrectomized rats to induce acidosis. Results. At sacrifice, the arterial pH and serum bicarbonate were lowest in the RF + Ac group and were intermediate in the N + Ac group. Serum creatinine (0.76 +/- 0.08 vs. 1.15 +/- 0.08 mg/dL), blood urea nitrogen (52 +/- 8 vs. 86 +/- 13 mg/dL), parathyroid hormone (PTH; 180 +/- 50 vs. 484 +/- 51 pg/mL), and serum phosphate (7.46 +/- 0.60 vs. 12.87 +/- 1.4 mg/dL) values were less (P < 0.05), and serum calcium (9.00 +/- 0.28 vs. 7.75 +/- 0.25 mg/dL) values were greater (P < 0.05) in the RF + Ac group than in the RF group. The fractional excretion of phosphate (FEp) was greater (P < 0.05) in the two azotemic groups than in the two nonazotemic groups. In the azotemic groups, the FEp was similar even though PTH and serum phosphate values were less in the RF + Ac than in the RF group. NH4Cl-induced acidosis produced hypercalciuria in the N + Ac and RF + Ac groups. When acid-loaded (N + Ac and RF + Ac) and non-acid-loaded (N and RF) rats were combined as separate groups, serum phosphate and PTH values were less for a similarly elevated serum creatinine value in acid-loaded than in non-acid-loaded rats. Finally, the osteoblast surface was less in the N + Ac group than in the other groups. However, in the acid-loaded azotemic group (RF + Ac), the osteoblast surface was not reduced. Conclusions. The presence of chronic metabolic acidosis in 5/6 nephrectomized rats on a high-phosphate diet (I) protected against the progression of RF, (2) enhanced the renal clearance of phosphate, (3) resulted in a lesser degree of hyperparathyroidism, and (4) did not reduce the osteoblast surface. The combination of metabolic acidosis and phosphate loading may protect against the progression of RF and possibly bone disease because the harmful effects of acidosis and phosphate loading may be counterbalanced.
引用
收藏
页码:1023 / 1032
页数:10
相关论文
共 17 条
  • [1] Role of PTH, phosphate, and metabolic acidosis in the progresion of renal disease in azotemic rats
    Jara, A
    Chacón, C
    Valdivieso, A
    Ibaceta, M
    NEFROLOGIA, 2003, 23 : 37 - 42
  • [2] Metabolic acidosis and the progression of chronic kidney disease
    Chen, Wei
    Abramowitz, Matthew K.
    BMC NEPHROLOGY, 2014, 15
  • [3] Urine Ammonium, Metabolic Acidosis and Progression of Chronic Kidney Disease
    Pourafshar, Negiin
    Pourafshar, Shirin
    Soleimani, Manoocher
    NEPHRON, 2018, 138 (03) : 222 - 228
  • [4] Does correction of metabolic acidosis slow chronic kidney disease progression?
    Goraya, Nimrit
    Wesson, Donald E.
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2013, 22 (02) : 193 - 197
  • [5] The Effect of Feeding a Renal Diet on Plasma Fibroblast Growth Factor 23 Concentrations in Cats with Stable Azotemic Chronic Kidney Disease
    Geddes, R. F.
    Elliott, J.
    Syme, H. M.
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2013, 27 (06) : 1354 - 1361
  • [6] Calcium phosphate microcrystals in the renal tubular fluid accelerate chronic kidney disease progression
    Shiizaki, Kazuhiro
    Tsubouchi, Asako
    Miura, Yutaka
    Seo, Kinya
    Kuchimaru, Takahiro
    Hayashi, Hirosaka
    Iwazu, Yoshitaka
    Miura, Marina
    Battulga, Batpurev
    Ohno, Nobuhiko
    Hara, Toru
    Kunishige, Rina
    Masutani, Mamiko
    Negishi, Keita
    Kario, Kazuomi
    Kotani, Kazuhiko
    Yamada, Toshiyuki
    Nagata, Daisuke
    Komuro, Issei
    Itoh, Hiroshi
    Kurosu, Hiroshi
    Murata, Masayuki
    Kuro-O, Makoto
    JOURNAL OF CLINICAL INVESTIGATION, 2021, 131 (16)
  • [7] Relationship of dietary phosphate intake with risk of end-stage renal disease and mortality in chronic kidney disease stages 3-5: The Modification of Diet in Renal Disease Study
    Selamet, Umut
    Tighiouart, Hocine
    Sarnak, Mark J.
    Beck, Gerald
    Levey, Andrew S.
    Block, Geoffrey
    Ix, Joachim H.
    KIDNEY INTERNATIONAL, 2016, 89 (01) : 176 - 184
  • [8] Effects of pyrrolidine dithiocarbamate on high-fat diet-induced metabolic and renal alterations in rats
    Ebenezer, Philip J.
    Mariappan, Nithya
    Elks, Carrie M.
    Haque, Masudul
    Soltani, Zohreh
    Reisin, Efrain
    Francis, Joseph
    LIFE SCIENCES, 2009, 85 (9-10) : 357 - 364
  • [9] Inactivation of Osteoblast PKC Signaling Reduces Cortical Bone Mass and Density and Aggravates Renal Osteodystrophy in Mice with Chronic Kidney Disease on High Phosphate Diet
    Zaloszyc, Ariane
    Choquet, Philippe
    Sayeh, Amira
    Bartosova, Maria
    Schaefer, Betti
    Huegel, Ulrike
    Aubertin-Kirch, Gaelle
    Healy, Christopher
    Severac, Francois
    Rizzo, Sebastien
    Boivin, Georges
    Schaefer, Franz
    Fischbach, Michel
    Bacchetta, Justine
    Bahram, Seiamak
    Schmitt, Claus Peter
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (12)
  • [10] Effect of Chronic Antioxidant Therapy with Superoxide Dismutase-Mimetic Drug, Tempol, on Progression of Renal Disease in Rats with Renal Mass Reduction
    Quiroz, Yasmir
    Ferrebuz, Atilio
    Vaziri, Nosratola D.
    Rodriguez-Iturbe, Bernardo
    NEPHRON EXPERIMENTAL NEPHROLOGY, 2009, 112 (01): : E31 - E42